Related Experiment Video

Updated: Aug 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

mTOR-independent translational control of the extrinsic cell death pathway by RalA

Amith Panner1, Jean L Nakamura, Andrew T Parsa

  • 1UCSF Cancer Center, 2340 Sutter St., Rm N219, San Francisco, CA 94115-0875, USA.

Molecular and Cellular Biology
|August 9, 2006
PubMed

Insights

Oncogenes regulate protein synthesis via mTOR, but RalA uses an mTOR-independent pathway to suppress tumor growth. This RalA function reactivates cell death, offering a therapeutic target for Ral-driven cancers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Translational Regulation

Background:

  • Oncogenic transformation is linked to translational control, with oncogenes often utilizing mTOR-dependent pathways.
  • The prevailing view suggests oncogenes enhance protein synthesis for transformation via mTOR signaling.
  • RalA is a key mediator of Ras-driven transformation and is connected to the translational machinery.

Purpose of the Study:

  • To investigate the role of RalA in translational regulation beyond mTOR-dependent pathways.
  • To elucidate the mechanism by which RalA influences protein synthesis and its impact on oncogenesis.
  • To explore the potential of targeting RalA pathways for cancer therapy.

Main Methods:

  • Investigated the interaction of RalA with the translational machinery.
  • Assessed the role of RalBP1 in suppressing cdc42-mediated activation of S6 kinase.
  • Examined the impact of RalA signaling on the translation of the antiapoptotic protein FLIP(S).
  • Evaluated the tumor-suppressive potential and therapeutic targeting of the Ral oncogenic program.

Main Results:

  • RalA's linkage to the translational machinery is partially independent of mTOR.
  • RalA, via RalBP1, suppresses cdc42-mediated activation of S6 kinase and FLIP(S) translation.
  • This action activates a latent tumor-suppressive mechanism, counteracting transformation.
  • Activation of this mechanism can be triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Conclusions:

  • The translational machinery is involved in both cell-proliferative and tumor-suppressive pathways.
  • RalA's function in translational regulation can suppress tumor growth by promoting apoptosis.
  • Targeting the Ral oncogenic program can reestablish cell death pathways, offering selective therapeutic strategies for Ral-driven malignancies.

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...